May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
In vivo Activation of Retinal Antigen Specific T-cells Alters Retinal Wound Healing in a Laser Injury Model
Author Affiliations & Notes
  • I.D. Subak-Sharpe
    Ophthalmology, Rayne Institute St Thomas Hospita, London, United Kingdom
  • K. Watts
    Ophthalmology, Rayne Institute St Thomas Hospita, London, United Kingdom
  • G. Wallace
    Ophthalmology, Rayne Institute St Thomas Hospita, London, United Kingdom
  • J. Marshall
    Ophthalmology, Rayne Institute St Thomas Hospita, London, United Kingdom
  • M.R. Stanford
    Ophthalmology, Rayne Institute St Thomas Hospita, London, United Kingdom
  • Footnotes
    Commercial Relationships  I.D. Subak-Sharpe, None; K. Watts, None; G. Wallace, None; J. Marshall, None; M.R. Stanford, None.
  • Footnotes
    Support  Special Trustees of Guy's and St Thomas'Hospital
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 569. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      I.D. Subak-Sharpe, K. Watts, G. Wallace, J. Marshall, M.R. Stanford; In vivo Activation of Retinal Antigen Specific T-cells Alters Retinal Wound Healing in a Laser Injury Model . Invest. Ophthalmol. Vis. Sci. 2003;44(13):569.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To determine whether the immuno-pathological features of retinal wound healing following laser-induced injury differ with or without in vivo activation of retinal antigen specific T-cells. Methods: Two groups of 16 PVG rats were used. In group 1, the animals received a controlled laser injury to one eye (Keeler diode laser, 6 discreet applications of 100µm, 100ms, 50mw), without immunisation. In group 2, animals were immunised subcutaneously with bovine retinal extract (containing 1mg/100µl) in complete Freund's adjuvant and intra-peritoneal pertussis toxin. At day 12 following immunisation, before any clinical signs of disease, one eye received the same laser protocol. Retinas were removed at 2 hours and 4, 7 and 28 days following laser injury and examined both histologically and by immunophenotyping (ED1, ED2, ED3, CD4, CD8 staining) of invading cells. T-cell proliferation assays of spleen cells were carried out using retinal extract as the antigen. Results: In group 1, there was an influx of ED1+ve macrophages from day 4 at the sites of laser injury, both within the sub-retinal space and in the localised glial scar. In group 2, a 5x increase of invading ED1 +ve macrophages in the sub-retinal space was observed from day 4, with widespread damage to the rod outer segments. There was also a massive infiltration of macrophages into the vitreous. In the control eyes of group 2, there was no histopathological evidence of inflammatory infiltration in the outer retina or vitreous. Immunisation led to a 3x increased stimulation index for the T-cell proliferation assay. Conclusions: In vivo activation of retinal antigen specific T-cells by immunisation heightens the tissue destructive response following laser injury by enhancing the cellular effector phase of the immune response. These results suggest that caution should be exercised when using laser retinal photocoagulation in patients with uveitis.

Keywords: uveitis-clinical/animal model • laser • autoimmune disease 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×